NovoCure (NVCR) Stock
NovoCure (NVCR) closed at $11.14 on Nov 17, 2026; its Tenet Score is 38 of 100 against 340 Healthcare peers.
21 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $11.14
- Nov 17, 2026
- Market cap
- $1.3B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 9.82 – 21.45
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 38/100
- Weak · 340 Healthcare peers
Industry: Health Services
NovoCure Ltd scores 38/100. Weak. Growth is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and Optune Lua, a Tumor Treating Fields (TTFields) devices for use as…
Similar-sized companies in Health Services
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Conmed Corp.CNMD | 56 | $1.5B |
| Phibro Animal Health Corp.PAHC | 50 | $1.4B |
| Cadre Holdings IncCDRE | 45 | $1.4B |
| ChronoScale Holdings Corp.CHRN | 42 | $1.4B |
| Tyra Biosciences IncTYRA | 65 | $1.4B |
| Procept BioRobotics CorpPRCT | 52 | $1.4B |
| InnovAge Holding CorpINNV | 45 | $1.3B |
| Staar Surgical Co.STAA | 47 | $1.3B |
| Pennant Group IncPNTG | 44 | $1.3B |
| Tandem Diabetes Care IncTNDM | 31 | $1.3B |
Common questions
What sector and industry is NovoCure in?
NovoCure is in the Healthcare sector and the Health Services industry.
What is NovoCure's Tenet Score?
NovoCure's Tenet Score is 38 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




